CNPR Drug Development Process 3

Question 1

Which of the following best describes the role of a 'placebo' in a controlled clinical trial?

Accepted Answer

An inactive substance used to eliminate bias when comparing treatment effects

Answer

A placebo is an inert treatment that controls for the psychological effects of receiving treatment, allowing true drug effects to be isolated.

Question 2

What is the 'patent cliff' in the pharmaceutical industry?

Accepted Answer

The sharp revenue decline a brand drug experiences when its patent expires and generics enter

Answer

When a blockbuster drug loses patent protection, generic competitors rapidly erode market share, causing a steep revenue drop known as the patent cliff.

Question 3

Post-marketing surveillance studies conducted after FDA approval are categorized as:

Accepted Answer

Phase IV studies

Answer

Phase IV studies occur after a drug is approved and marketed, monitoring long-term safety and effectiveness in the general population.

Question 4

Which document must a pharmaceutical sales representative provide to a healthcare provider that summarizes FDA-approved prescribing information?

Accepted Answer

The Package Insert (PI) / Prescribing Information

Answer

The package insert (prescribing information) is the FDA-approved label containing indications, dosing, contraindications, warnings, and clinical data.

Question 5

The FDA's 'Orphan Drug Act' provides incentives for developing drugs that treat diseases affecting fewer than how many people in the US?

Accepted Answer

200,000

Answer

The Orphan Drug Act defines rare diseases as those affecting fewer than 200,000 people in the US and provides tax credits, grants, and 7-year market exclusivity.

(CNPR) Certified National Pharmaceutical Representative Practice Test

(CNPR) Certified National Pharmaceutical Representative Practice Test

CNPR Drug Development Process 3